Optimizing weight control in diabetes: antidiabetic drug selection

Código QR

Optimizing weight control in diabetes: antidiabetic drug selection

S Kalra1, B Kalra1, AG Unnikrishnan2, N Agrawal3, S Kumar41Bharti Hospital, Karnal; 2Amrita Institute of Medical Science, Kochi; 3Medical College, Gwalior; 4Excel Life Sciences, Noida, IndiaDate of preparation: 18th August 2010Conflict of interest: SK has received speaker fees from Novo Nordisk, san...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	S Kalra, B Kalra, AG Unnikrishnan, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/780c84b46b5e4852bc66635152f4d5b5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Optimizing weight control in diabetes: antidiabetic drug selection
por: Kalra S
Publicado: (2010)

Antidiabetic effect of glucosaminic acid-cobalt (II) chelate in streptozotocin-induced diabetes in mice
por: Talba T, et al.
Publicado: (2011)

Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
por: Kapoor S
Publicado: (2012)

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes
por: Bradley Curtis, et al.
Publicado: (2008)

Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
por: Kalra S, et al.
Publicado: (2021)

Predictors of weight loss and maintenance in patients treated with antiobesity drugs
por: Guaraldi F, et al.
Publicado: (2011)

Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes
por: Priyanka Gunasekara, et al.
Publicado: (2011)

Using a technology-based intervention to promote weight loss in sedentary overweight or obese adults: a randomized controlled trial study design
por: Vaughn W Barry, et al.
Publicado: (2011)

Imaging body composition in obesity and weight loss: challenges and opportunities
por: Heidi J Silver, et al.
Publicado: (2010)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Michael A Via, et al.
Publicado: (2010)

Glycemic control and anti-osteopathic effect of propolis in diabetic rats
por: Al-Hariri M,&nbsp;Gamal Eldin T, et al.
Publicado: (2011)

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
por: Henri K Parson, et al.
Publicado: (2010)

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study
por: Hernández-Ojeda J, et al.
Publicado: (2014)

Antidiabetic Effects of Physical Activity: How It Helps to Control Type 2 Diabetes
por: Wake AD
Publicado: (2020)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
por: Anderson M, et al.
Publicado: (2014)

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
por: Powell DR, et al.
Publicado: (2015)

Effect of Holostemma annularis on the progression of diabetes induced by a high fructose diet in rats and in diabetic C57BL/6J ob/ob mice
por: Sudharshan Reddy D, et al.
Publicado: (2010)

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
por: Alaa Badawi, et al.
Publicado: (2010)

Lorcaserin for weight management
por: Taylor JR, et al.
Publicado: (2013)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
por: Irons BK, et al.
Publicado: (2014)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Joshua J Neumiller, et al.
Publicado: (2010)

Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
por: Nanne Kleefstra, et al.
Publicado: (2009)

p38 MAPK inhibition reduces diabetes-induced impairment of wound healing
por: Satyanarayana Medicherla, et al.
Publicado: (2009)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
por: Irons BK, et al.
Publicado: (2017)

HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?
por: Kowall B, et al.
Publicado: (2013)

Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-&kappa;B suppression
por: Sirada Rungseesantivanon, et al.
Publicado: (2010)

Impact of obesity and type 2 diabetes on health-related quality of life in the general population in England
por: Stephen CL Gough, et al.
Publicado: (2009)

Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes
por: Sheri R Colberg, et al.
Publicado: (2010)

High-sensitivity C-reactive protein concentrations among patients with and without diabetes in a multiethnic population of Singapore: CREDENCE Study
por: Rinkoo Dalan, et al.
Publicado: (2010)

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
por: Angel Rodr&iacute;guez, et al.
Publicado: (2010)

Antidiabetic and Anti-hyperlipidemic Effects of the Crude Hydromethanol Extract of Hagenia abyssinica (Rosaceae) Leaves in Streptozotocin-Induced Diabetic Mice
por: Kifle ZD, et al.
Publicado: (2020)

TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
por: Shitalkumar P Zambad, et al.
Publicado: (2011)

Effect of a low-carbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participants
por: Marion L Vetter, et al.
Publicado: (2010)

Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism
por: Mauro AM Carai, et al.
Publicado: (2009)

Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children
por: Hartman ML, et al.
Publicado: (2014)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Stanley S Schwartz
Publicado: (2010)

Mechanism linking diabetes mellitus and obesity
por: Al-Goblan AS, et al.
Publicado: (2014)

Evaluation of Antidiabetic Effect of Ethanolic Leaves Extract of Becium grandiflorum Lam. (Lamiaceae) in Streptozotocin-Induced Diabetic Mice
por: Gebremeskel L, et al.
Publicado: (2020)

Effect of weight loss on adipokine levels in obese patients
por: Hession M, et al.
Publicado: (2011)

Comorbidity and glycemia control among patients with type 2 diabetes in primary care
por: Catherine Hudon, et al.
Publicado: (2008)